Repatha 140 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DB25FQ78U
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $40,863
Award facts
- Contract value 100% obligated
- $40,863.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $40,863.12 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for Repatha 140 mg/ml SureClick auto-injectors. This is a firm fixed-price, non-set-aside contract with a completion date of September 19, 2025, and performance at the vendor's Conshohocken, Pennsylvania facility. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that supplies a comprehensive range of pharmaceutical products and medical supplies to federal customers, particularly through the Defense Logistics Agency and its Medical Supply Chain. Repatha is a PCSK9 inhibitor used for cholesterol management and cardiovascular disease prevention, representing the type of specialty medication within the company's extensive portfolio of therapeutics. The company's federal contract awards demonstrate consistent capability in meeting competitive procurement requirements across multiple therapeutic domains, from brand-name specialty medications to generics, vaccines, and medical devices supporting military healthcare systems worldwide.
Quick answers
Who was awarded contract SPE2DB25FQ78U?
SPE2DB25FQ78U was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 18, 2025.
How much is contract SPE2DB25FQ78U worth?
The government has obligated $40,863 on SPE2DB25FQ78U.
Is contract SPE2DB25FQ78U an order under another contract?
Yes. SPE2DB25FQ78U is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FQ78U competed?
The extent of competition for SPE2DB25FQ78U was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award